Payer Perspectives on Real World Data and Evidence
Compelling real-world evidence (RWE) of a product’s utility and value is increasingly critical if pharma is to win the support of payers. But how are payers using RWE, what do they want and how can pharma deliver the RWE that really informs payer decision-making? Why are patient-reported outcomes growing in importance? How might AI, data analytics and wearable technology change the RWE landscape? In this report US and European payers reveal how RWE is influencing their decision-making and how data and information trends will shape the future.
Companies
Amgen, Novartis, Lilly, Roche, GlaxoSmithKline, AstraZeneca, Pfizer, Merck & Co., Astellas, Spark Therapeutics, Cigna, EMD Serono, IQVIA, Aetna, Prime Therapeutics, Celgene, Havard Pilgrim
- Subject synopsis
- Research methodology and objectives
- Experts interviewed
- Key research objectives
- Key insights summary
- Issues and insights
- Payer landscape
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Factors to consider when payers use RWD/RWE
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Challenges and implications of utilising RWE in payer decision-making
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Future outlook: RWE in payer decision-making and market access
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Further Reading
- Abbreviations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook